Shares are up 7% in trading today, after Geron announced a strategic restructuring to "position the company for long-term ...
Structure Therapeutics (GPCR) delivered robust Phase 2b results for aleniglipron, surpassing key efficacy and tolerability thresholds for oral GLP-1 therapies. GPCR now appears competitive with top ...
With the other premium services, you can dive deep into additional metrics, portfolios, commentary and information about ...
AlphaFold didn't accelerate biology by running faster experiments. It changed the engineering assumptions behind protein structure prediction.
RECALL ALERT: There are 5 recalls on this vehicle. Learn More. There are 5 recalls on this vehicle. Learn More. RECALL ALERT: There are 5 recalls on this vehicle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results